WallStreetZenWallStreetZen

NASDAQ: RANI
Rani Therapeutics Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RANI

Based on 3 analysts offering 12 month price targets for Rani Therapeutics Holdings Inc

Min Forecast
$4.00+81.82%
Avg Forecast
$8.33+278.77%
Max Forecast
$11.00+400%

Should I buy or sell RANI stock?

Based on 3 analysts offering ratings for Rani Therapeutics Holdings Inc.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RANI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RANI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their RANI stock forecasts and price targets.

RANI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-21
lockedlocked$00.00+00.00%2025-10-20
lockedlocked$00.00+00.00%2025-05-16

1 of 1

Forecast return on equity

Is RANI forecast to generate an efficient return?

Forecast return on assets

Is RANI forecast to generate an efficient return on assets?

Company
-90.02%
Industry
106.32%
RANI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RANI earnings per share forecast

What is RANI's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.55
Avg 2 year Forecast
-$0.41
Avg 3 year Forecast
-$0.39

RANI revenue forecast

What is RANI's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$189.7k-84.19%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%

RANI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RANI$2.20$8.33+278.77%Strong Buy
AGEN$3.97$14.50+265.24%Buy
HURA$2.55$12.00+370.59%Buy
GLSI$9.21N/AN/A
INO$2.35$6.50+176.60%Buy
View Top Biotech Stocks

Rani Therapeutics Holdings Stock Forecast FAQ

Is Rani Therapeutics Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RANI) stock is to Strong Buy RANI stock.

Out of 3 analysts, 1 (33.33%) are recommending RANI as a Strong Buy, 2 (66.67%) are recommending RANI as a Buy, 0 (0%) are recommending RANI as a Hold, 0 (0%) are recommending RANI as a Sell, and 0 (0%) are recommending RANI as a Strong Sell.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.

What is RANI's earnings growth forecast for 2025-2027?

(NASDAQ: RANI) Rani Therapeutics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 37.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41%.

Rani Therapeutics Holdings's earnings in 2025 is -$29,799,000.On average, 6 Wall Street analysts forecast RANI's earnings for 2025 to be -$31,694,191, with the lowest RANI earnings forecast at -$33,270,845, and the highest RANI earnings forecast at -$29,605,413. On average, 5 Wall Street analysts forecast RANI's earnings for 2026 to be -$23,770,644, with the lowest RANI earnings forecast at -$25,376,068, and the highest RANI earnings forecast at -$21,750,916.

In 2027, RANI is forecast to generate -$22,303,320 in earnings, with the lowest earnings forecast at -$21,992,593 and the highest earnings forecast at -$22,355,108.

What is RANI's revenue growth forecast for 2025-2027?

(NASDAQ: RANI) Rani Therapeutics Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.

Rani Therapeutics Holdings's revenue in 2025 is $1,200,000.On average, 5 Wall Street analysts forecast RANI's revenue for 2025 to be $10,916,888, with the lowest RANI revenue forecast at $9,699,297, and the highest RANI revenue forecast at $12,083,842. On average, 5 Wall Street analysts forecast RANI's revenue for 2026 to be $0, with the lowest RANI revenue forecast at $0, and the highest RANI revenue forecast at $0.

In 2027, RANI is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is RANI's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: RANI) forecast ROA is -90.02%, which is lower than the forecast US Biotechnology industry average of 106.32%.

What is RANI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RANI price target, the average RANI price target is $8.33, with the highest RANI stock price forecast at $11.00 and the lowest RANI stock price forecast at $4.00.

On average, Wall Street analysts predict that Rani Therapeutics Holdings's share price could reach $8.33 by Oct 21, 2026. The average Rani Therapeutics Holdings stock price prediction forecasts a potential upside of 278.77% from the current RANI share price of $2.20.

What is RANI's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: RANI) Rani Therapeutics Holdings's current Earnings Per Share (EPS) is -$0.99. On average, analysts forecast that RANI's EPS will be -$0.55 for 2025, with the lowest EPS forecast at -$0.58, and the highest EPS forecast at -$0.51. On average, analysts forecast that RANI's EPS will be -$0.41 for 2026, with the lowest EPS forecast at -$0.44, and the highest EPS forecast at -$0.38. In 2027, RANI's EPS is forecast to hit -$0.39 (min: -$0.38, max: -$0.39).

What is RANI's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: RANI) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.